- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Regulatory T cells in immune checkpoint blockade antitumor therapy ; volume:23 ; number:1 ; day:8 ; month:11 ; year:2024 ; pages:1-22 ; date:12.2024
Molecular cancer ; 23, Heft 1 (8.11.2024), 1-22, 12.2024
- Urheber
-
Zhang, An
Fan, Tao
Liu, Yixiao
Yu, Guanhua
Li, Chunxiang
Jiang, Zheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-024-02156-y
- URN
-
urn:nbn:de:101:1-2501262107250.384760868148
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, An
- Fan, Tao
- Liu, Yixiao
- Yu, Guanhua
- Li, Chunxiang
- Jiang, Zheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma